AR and glioblastoma: Fascinatingly, suppressing AR activity with enzalutamide, a specific inhibitor of the AR [25], concurrently attenuated testosterone-induced enhancements of cell proliferation and colony formation in human U87 MG and GBM5401 glioblastoma cells.